Latest news
Pacira BioSciences (PCRX) Could Be 35% Undervalued On Phase 1 Gene Therapy Progress - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 21:14:02 GMTOpus Genetics Reports Q2 2026 Results and Advances Multiple IRD Gene Therapy Programs with OPGx-BEST1 Data Expected in September - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:15:00 GMT6-Month summary of gene therapy advances in ocular diseases - Ophthalmology Times EuropeOphthalmology Times Europe · Mon, 03 Aug 2026 19:00:51 GMTGenetic Complexity Behind EB Simplex Slows Gene Therapy Progress - Dermatology TimesDermatology Times · Wed, 29 Jul 2026 07:00:00 GMT